The Changing Landscape of Gene Therapy
Frank Tagliaferri, Ph.D., VP of Pharmaceutical Development & GM Biocompare, The Buyer’s Guide for Life Sciences Published an Article: The
Uncategorized
Life Sciences
Uncategorized
Pace® Life Sciences Acquires Velesco Pharmaceutical Services
Acquisition adds significant experience and expertise in the development of liquid, semi-solid, and oral solid dose products for pre-clinical and clinical use
Uncategorized
Pace Life Sciences Acquires Drug Delivery Experts, Expanding Capacity and Injectable Drug Product Services
Acquisition allows Pace to support a growing number of clients requiring services throughout the drug development process while adding expertise
Uncategorized
PRESS RELEASE: June 2021: Installation and validation of LIMS is complete in our Philadelphia site!
The installation and validation of our LabVantage Laboratory Information Management System (LIMS) is complete in our Philadelphia site! Staff
Uncategorized
Delivering Science Better; Advancing Novel Therapies Through the Clinic to Commercialization
Frank Tagliaferri, Ph.D., VP of Pharmaceutical Development & GM Drug Development and Delivery recently interviewed our very own, Frank Tagliaferri,
Pace Analytical® Chief Compliance Officer Appointed to California Environmental Laboratory Technical Advisory Committee
Pace Analytical® Chief Compliance Officer Appointed to California Environmental Laboratory Technical Advisory Committee Judy Morgan of Pace joins group providing
Uncategorized
On-Demand Webinar Lyophilized Drug Product Development
Summary: In an effort to improve stability and shelf life of a drug, the active ingredients in many therapeutics are
Uncategorized
Live Webcast: Understanding Polymorphism to De-Risk Drug Development
Thursday, October 15, 2020 at 11am EDT| 8am PDT| 4pm BST| 5pm CEST Event Overview: Determining the polymorphism of a
Uncategorized
ON DEMAND WEBINAR: Pharmaceutical Development of Oligonucleotides
ON DEMAND WEBINAR: Pharmaceutical Development of Oligonucleotides Oligonucleotides are an emerging class of DNA and RNA therapeutics that address a
Uncategorized
Enzyme-Nano Interactions: Implications of Nanomaterials on Cytochrome P450 Enzymes By Nishan Shah, Ph.D
Check out Nishan Shah, Ph.D’s publication in AAPS News Magazine! Read More…